Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-01
DOI
10.1111/cas.14917
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
- (2020) Yingge Liu et al. Clinical Epigenetics
- Dietary factors and risk of mortality among patients with esophageal cancer: a systematic review
- (2020) Li-Ping Sun et al. BMC CANCER
- Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer
- (2020) Tzu-Ting Huang et al. CANCER TREATMENT REVIEWS
- Targeting the PI3K/mTOR pathway augments CHK1 inhibitor-induced replication stress and antitumor activity in high-grade serous ovarian cance
- (2020) Tzu-Ting Huang et al. CANCER RESEARCH
- Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
- (2020) Jianjun Yang et al. Frontiers in Oncology
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The mTOR pathway: Implications for DNA replication
- (2019) Noa Lamm et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Ovarian cancer detection by DNA methylation in cervical scrapings
- (2019) Tzu-I Wu et al. Clinical Epigenetics
- Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells
- (2019) Sameer S. Chopra et al. Cell Systems
- The Key Role of Epigenetics in Human Disease Prevention and Mitigation
- (2018) Andrew P. Feinberg NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oesophageal cancer
- (2017) Jesper Lagergren et al. LANCET
- Marked for death: targeting epigenetic changes in cancer
- (2017) Sophia Xiao Pfister et al. NATURE REVIEWS DRUG DISCOVERY
- Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer
- (2017) Tao He et al. Epigenomics
- New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints
- (2016) V. E. Wang et al. CLINICAL CANCER RESEARCH
- Neuritin Up-regulates Kv4.2 α-Subunit of Potassium Channel Expression and Affects Neuronal Excitability by Regulating the Calcium-Calcineurin-NFATc4 Signaling Pathway
- (2016) Jin-jing Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling
- (2016) Baoping Cao et al. Journal of Thoracic Oncology
- Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
- (2016) Ashish Juvekar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of neuritin in gastric cancer
- (2015) MING YUAN et al. Oncology Letters
- Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
- (2015) Yan Dong et al. Oncotarget
- The Synergistic Effects of Alcohol and Tobacco Consumption on the Risk of Esophageal Squamous Cell Carcinoma: A Meta-Analysis
- (2014) Anoop Prabhu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
- (2014) Susan J Dutton et al. LANCET ONCOLOGY
- Identification of genomic alterations in oesophageal squamous cell cancer
- (2014) Yongmei Song et al. NATURE
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- DACT2 Is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma
- (2013) J. Hou et al. Cancer Prevention Research
- Epigenetic regulation ofDACH1, a novel Wnt signaling component in colorectal cancer
- (2013) Wenji Yan et al. Epigenetics
- Neuritin Activates Insulin Receptor Pathway to Up-regulate Kv4.2-mediated Transient Outward K+Current in Rat Cerebellar Granule Neurons
- (2012) Jin-Jing Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer
- (2012) Yan Jia et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Inhibitors of Phosphatidylinositol 3′-Kinases Promote Mitotic Cell Death in HeLa Cells
- (2012) Heli Hou et al. PLoS One
- Methylation of TFPI-2 is an early event of esophageal carcinogenesis
- (2012) Yan Jia et al. Epigenomics
- Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma
- (2011) A. Vincent et al. CLINICAL CANCER RESEARCH
- Promoter methylation ofHIN-1in the progression to esophageal squamous cancer
- (2010) MingZhou Guo et al. Epigenetics
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Neuritin expression and its relation with proliferation, apoptosis, and angiogenesis in human astrocytoma
- (2010) Lei Zhang et al. MEDICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now